Palavras-chave
APOE
APOB
genética
Como Citar
Resumo
Dyslipidemias are closely associated to the development of cardiovascular and cerebrovascular diseases, and therefore of great importance in public health. Many genes influence lipid levels, such as APOE and APOB. The present study aimed to investigate the effects of APOE gene alleles (rs7412: C>T and rs429358: T>C), and R3500Q mutation of APOB gene (rs5742904: G>A) in lipid levels in a South Brazilian cohort. 214 individuals were analyzed and the frequencies of APOE ε2, ε3 and ε4 alleles were found respectively as 9.25 ± 0.4625; 70.5 ± 3.525 and 20.25%± 1.401, while the frequency of R3500Q mutation of the APOB gene was 4.46 ± 1.00%. The ε4 allele was significantly more frequent in subjects with higher TC (Total Cholesterol) and LDL-C levels, while significantly higher frequency of the ε2 allele was found in individuals with higher HDL-C levels. The R3500Q mutation was suggested as a risk factor for higher TC levels, regardless gender and age (β = 21.326 ± 10377.78, p = 0.001).
Referências
Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk. JAMA [Internet]. 2007 Sep 19 [cited 2017 Nov 13];298(11):1300. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.298.11.1300
Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, et al. Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease. J Am Coll Cardiol [Internet]. 2012 Dec 25 [cited 2017 Nov 13];60(25):2631–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23083789
Maria V, Polachini B-V, Zanardo-Giovana S, Ceni C. Avaliação Do Perfil Lipídico Dos Pacientes Com Dislipidemia Atendidos No Ambulatório De Especialidades De Nutrição Da Uricepp. 2011;3512935129:177–88.
Tóth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006. J Clin Lipidol [Internet]. 2012 Jul [cited 2017 Nov 13];6(4):325–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22836069
Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet [Internet]. 2010 Nov 13 [cited 2017 Nov 13];376(9753):1670–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21067804
Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol [Internet]. 2013 [cited 2017 Nov 13];101(4):01–22. Available from: http://www.gnresearch.org/doi/10.5935/abc.2013S010
Shen H, Damcott CM, Rampersaud E, Pollin TI, Horenstein RB, McArdle PF, et al. Familial Defective Apolipoprotein B-100 and Increased Low-Density Lipoprotein Cholesterol and Coronary Artery Calcification in the Old Order Amish. Arch Intern Med [Internet]. 2010 Nov 8 [cited 2017 Nov 13];170(20):1850–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21059979
Nelken J, Meshkani R, Chahal N, McCrindle B, Adeli K. Detection of familial defective apoB (FDB) mutations in hypercholesterolemic children and adolescents by denaturing high performance liquid chromatography (DHPLC). Clin Biochem [Internet]. 2008 Apr [cited 2017 Nov 13];41(6):395–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18222178
Ward H, Mitrou PN, Bowman R, Luben R, Wareham NJ, Khaw K-T, et al. APOE genotype, lipids, and coronary heart disease risk: a prospective population study. Arch Intern Med [Internet]. 2009;169(15):1424–9. Available from: http://archinte.jamanetwork.com/article.aspx?articleid=1108512
Blackhart BD, Ludwig EM, Pierotti VR, Caiati L, Onasch M a, Wallis SC, et al. Structure of the human apolipoprotein B gene. J Biol Chem. 1986;261(14):15364–7.
Innerarity TL, Weisgraber KH, Arnold KS, Mahley RW, Krauss RM, Vega GL, et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A [Internet]. 1987;84(19):6919–23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=299196&tool=pmcentrez&rendertype=abstract
Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Vol. 104, Atherosclerosis. 1993. p. 1–18.
Soria LF, Ludwig EH, Clarke HRG, Vegat GL, Grundyt SM, Mccarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 (genetic disease/cholesterol metabolism). Genetics. 1989;86(January):587–91.
SNPedia [Internet]. [cited 2017 Nov 13]. Available from: https://www.snpedia.com/index.php/SNPedia
Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (80- ) [Internet]. 1988;240(4852):622–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3283935
Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 1981;256(17):9077–83.
Lahiri DK, Numberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19(19):5444.
Jakobsson M, Rosenberg NA. CLUMPP: A cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure. Bioinformatics. 2007;23(14):1801–6.
Crook MA. Plasma lipids and lipoproteins. Clin Biochem Metab Med. 2012;200–15.
Turek LV, Leite N, Souza RLR, Lima JK, Milano GE, da Silva Timossi L, et al. Gender-dependent association of HSD11B1 single nucleotide polymorphisms with glucose and HDL-C levels. Genet Mol Biol. 2014;37(3):490–5.
Barat P, Livingstone DEW, Elferink CMC, McDonnell CR, Walker BR, Andrew R. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats. Endocrinology. 2007;148(10):4836–43.
Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, et al. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest [Internet]. 1995;95(3):1225–34. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=441461&tool=pmcentrez&rendertype=abstract
Gaffney D, Reid JM, Cameron IM, Vass K, Caslake MJ, Shepherd J, et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. ArteriosclerThrombVascBiol. 1995;15(1079–5642):1025–9.
Fard-Esfahani P, Mohammadi-Torbati P, Khatami S, Zeinali S, Taghikhani M, Allahyari M. Familial defective apoliporrotein B 100: Frequency of R3500Q mutation of apoliporotein B gene in Iranian hypercholesterolemic patients. Acta Med Iran. 2005;43(3):193–6.
Awad NS, El-Tarras AE-S. Analysis of the APO B R3500Q Mutation and APOE Polymorphism in Taif Saudi Population using Polymerase Chain Reaction- Reveres Hybridization Technique. J Mol Biomark Diagn [Internet]. 2011 Jun 28 [cited 2017 Nov 13];2(1). Available from: https://www.omicsonline.org/analysis-of-the-apo-b-r3500q-mutation-and-apoe-polymorphism-in-taif-saudi-population-using-polymerase-chain-reaction-reveres-hybridization-technique-2155-9929.1000109.php?aid=1448
Souza DRS, Nakachima L, Biagioni RB, Nakazone MA, Pinhel MAS, Trindade DM, et al. Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease. BRAZILIAN J Med Biol Res. 2007;40(2):189–97.
Granér M, Kahri J, Varpula M, Salonen RM, Nyyssönen K, Jauhiainen M, et al. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. Nutr Metab Cardiovasc Dis [Internet]. 2008;18(4):271–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17462871
Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem [Internet]. 1982 Mar 10 [cited 2017 Nov 13];257(5):2518–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6277903
Han S, Xu Y, Gao M, Wang Y, Wang J, Liu Y, et al. Serum apolipoprotein E concentration and polymorphism influence serum lipid levels in Chinese Shandong Han population. Medicine (Baltimore) [Internet]. 2016 Dec [cited 2017 Nov 13];95(50):e5639. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27977609
Ferreira CN, Carvalho MG, Fernandes APSM, Lima LM, Loures-Valle AA, Dantas J, et al. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders. Neurochem Int. 2010;56(1):177–82.
Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, et al. Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta. 2000;300(1–2):139–49.
Freitas RGA de, Campana EMG, Pozzan R, Brandão AA, Brandão AP, Magalhães MEC, et al. APOE and LDLR Gene Polymorphisms and Dyslipidemia Tracking. Rio de Janeiro Study. Arq Bras Cardiol [Internet]. 2015; Available from: http://www.gnresearch.org/doi/10.5935/abc.20150036
Villeneuve S, Brisson D, Gaudet D. Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality. J Lipids [Internet]. 2015 Oct 28 [cited 2017 Nov 13];2015:1–10. Available from: http://www.hindawi.com/journals/jl/2015/742408/
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Caroline Cardozo Gasparin, Luciane Viater Tureck, Lilian Pereira Ferrari, Ricardo Lehtonen Rodrigues de Souza, Lupe Furtado Alle